Stephen Hanauer, MD, from Northwestern Medicine, answers our questions about the use of biosimilars in the management of IBD ahead of his presentation at the Advances in Inflammatory Bowel Diseases (AIBD)...
Stephen Hanauer, MD, from Northwestern Medicine, answers our questions about the use of biosimilars in the management of IBD ahead of his presentation at the Advances in Inflammatory Bowel Diseases (AIBD)...
Stephen Hanauer, MD, from Northwestern Medicine, answers our questions about the use of biosimilars in the management of IBD ahead of his presentation at the Advances in Inflammatory Bowel Diseases (AIBD)...
Mohammed Absar Ullah, MD, and Shivangi Kothari, MD, answer our questions about their study of early cholecystectomy to prevent recurrent biliary events among individuals with acute biliary pancreatitis.
...
Mohammed Absar Ullah, MD, and Shivangi Kothari, MD, answer our questions about their study of early cholecystectomy to prevent recurrent biliary events among individuals with acute biliary pancreatitis.
...
Mohammed Absar Ullah, MD, and Shivangi Kothari, MD, answer our questions about their study of early cholecystectomy to prevent recurrent biliary events among individuals with acute biliary pancreatitis.
...
Elizabeth Volkmann, MD, MS, from the University of California, Los Angeles, answers our questions about her study that assessed predictors of survival among patients with systemic sclerosis-interstitial...
Laura T. Safar, MD, from Brigham and Women's Hospital, answers our questions about the use of psychotropics in patients with multiple sclerosis. Read more about her tips for managing drug-drug...
Laura T. Safar, MD, from Brigham and Women's Hospital, answers our questions about the use of psychotropics in patients with multiple sclerosis. Read more about her tips for managing drug-drug...
Laura T. Safar, MD, from Brigham and Women's Hospital, answers our questions about the use of psychotropics in patients with multiple sclerosis. Read more about her tips for managing drug-drug...
